HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 22.62 Million USD | -0.05% |
| 2021 | 22.63 Million USD | -6.24% |
| 2020 | 24.14 Million USD | -17.47% |
| 2019 | 29.25 Million USD | -10.19% |
| 2018 | 32.57 Million USD | 18.4% |
| 2017 | 27.51 Million USD | 8.62% |
| 2016 | 25.32 Million USD | 29.25% |
| 2015 | 19.59 Million USD | 51.05% |
| 2014 | 12.97 Million USD | 8.91% |
| 2013 | 11.91 Million USD | 6.23% |
| 2012 | 11.21 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | - USD | -100.0% |
| 2023 Q1 | 4.89 Million USD | -1.26% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q4 | 4.95 Million USD | 0.61% |
| 2022 Q2 | 6.15 Million USD | -6.52% |
| 2022 Q1 | 6.58 Million USD | 2.04% |
| 2022 Q3 | 4.92 Million USD | -19.92% |
| 2022 FY | 22.62 Million USD | -0.05% |
| 2021 Q2 | 5.18 Million USD | -0.89% |
| 2021 Q3 | 5.76 Million USD | 11.22% |
| 2021 FY | 22.63 Million USD | -6.24% |
| 2021 Q4 | 6.45 Million USD | 11.87% |
| 2021 Q1 | 5.23 Million USD | -5.66% |
| 2020 Q4 | 5.54 Million USD | -7.7% |
| 2020 Q3 | 6 Million USD | 0.33% |
| 2020 Q2 | 5.98 Million USD | -9.29% |
| 2020 Q1 | 6.6 Million USD | -14.22% |
| 2020 FY | 24.14 Million USD | -17.47% |
| 2019 FY | 29.25 Million USD | -10.19% |
| 2019 Q4 | 7.69 Million USD | 8.6% |
| 2019 Q3 | 7.08 Million USD | -11.35% |
| 2019 Q2 | 7.99 Million USD | 23.45% |
| 2019 Q1 | 6.47 Million USD | -24.09% |
| 2018 FY | 32.57 Million USD | 18.4% |
| 2018 Q4 | 8.53 Million USD | 3.13% |
| 2018 Q1 | 8.24 Million USD | 0.14% |
| 2018 Q2 | 7.52 Million USD | -8.77% |
| 2018 Q3 | 8.27 Million USD | 9.94% |
| 2017 Q4 | 8.23 Million USD | 6.45% |
| 2017 FY | 27.51 Million USD | 8.62% |
| 2017 Q1 | 5.5 Million USD | 0.68% |
| 2017 Q2 | 6.03 Million USD | 9.57% |
| 2017 Q3 | 7.73 Million USD | 28.26% |
| 2016 Q3 | 5.84 Million USD | -20.16% |
| 2016 Q2 | 7.32 Million USD | 9.52% |
| 2016 Q1 | 6.68 Million USD | 16.07% |
| 2016 FY | 25.32 Million USD | 29.25% |
| 2016 Q4 | 5.46 Million USD | -6.49% |
| 2015 FY | 19.59 Million USD | 51.05% |
| 2015 Q1 | 4.12 Million USD | 18.49% |
| 2015 Q4 | 5.76 Million USD | 14.62% |
| 2015 Q3 | 5.02 Million USD | 7.42% |
| 2015 Q2 | 4.67 Million USD | 13.38% |
| 2014 FY | 12.97 Million USD | 8.91% |
| 2014 Q3 | 3.26 Million USD | -1.05% |
| 2014 Q2 | 3.29 Million USD | 12.29% |
| 2014 Q1 | 2.93 Million USD | 15.74% |
| 2014 Q4 | 3.48 Million USD | 6.84% |
| 2013 Q4 | 2.53 Million USD | 35.25% |
| 2013 FY | 11.91 Million USD | 6.23% |
| 2013 Q2 | 2.02 Million USD | 0.0% |
| 2013 Q3 | 1.87 Million USD | -7.58% |
| 2012 FY | 11.21 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -2056.69% |
| Arrayit Corporation | 6.19 Million USD | -265.041% |
| Atlantic International Corp. | 5.57 Million USD | -305.568% |
| Biocept, Inc. | 29.4 Million USD | 23.051% |
| Bioqual, Inc. | 7.44 Million USD | -203.724% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -2829.99% |
| DermTech, Inc. | 104.01 Million USD | 78.25% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 86.412% |
| iMD Companies, Inc. | 151.8 Thousand USD | -14802.728% |
| IDenta Corp. | 662.97 Thousand USD | -3312.449% |
| Interpace Biosciences, Inc. | 20.23 Million USD | -11.821% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -58086.986% |
| InVitro International | 661.32 Thousand USD | -3320.968% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -218.733% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -38831.171% |
| Medical Imaging Corp. | 1.91 Million USD | -1083.145% |
| NovelStem International Corp. | 3.53 Million USD | -539.485% |
| Optigenex Inc. | 1.28 Million USD | -1656.676% |
| PharmChem, Inc. | 2.93 Million USD | -671.816% |
| Proteome Sciences plc | 3.26 Million USD | -592.279% |
| Response Genetics, Inc | 25.31 Million USD | 10.645% |
| Rennova Health, Inc. | 7.67 Million USD | -194.664% |
| RushNet, Inc. | 1.78 Million USD | -1164.373% |
| ScreenPro Security Inc. | 3.23 Million USD | -598.496% |
| Stella Diagnostics Inc. | 11.42 Million USD | -97.985% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -208.098% |
| Todos Medical Ltd. | 14.05 Million USD | -60.931% |